These findings suggest that ABCA1 and CPT1 are indispensable for the beneficial effects of circRNA_0001805 against lipid metabolism disorder during NAFLD progression, and the molecules exert their effects by closely regulating the NF-κB signaling pathway. The gene discussed is NFKB1; the disease is metabolic dysfunction-associated steatotic liver disease.